Riskpilot← Back to searchSign inGet full accessLECARDIO AS
ASActiveOrg 990988226Wieses Gate 3, 2609 LillehammerMedical specialists activities · NACE 8622Est. 20072 employees
Revenue 2024
NOK 9,7M
+12% vs 2023
EBITDA margin
64.3%
+60% vs 2023
Equity ratio
72.9%
Financial strength
Net profit 2024
NOK 7,1M
+64% vs 2023
| Revenue | NOK 9,7M | +12% |
| EBITDA | NOK 6,3M | +60% |
| Net profit | NOK 7,1M | +64% |
| Total assets | NOK 43,5M | +17% |
| Equity | NOK 31,8M | +19% |
| Employees | 2 | — |
Legal name
LECARDIO AS
Org number
990988226
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
17. mars 2007
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Spesialisthelsetjeneste i cardiologi/indremedisin.
Address
Wieses Gate 3, 2609 Lillehammer
Phone
+4791223344
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 069 | 8 167 | 8 810 | 8 709 | 9 718 |
| Staff expenses | −1 744 | −5 655 | −4 351 | −3 734 | −2 483 |
| EBITDA | 5 364 | 1 531 | 3 555 | 3 916 | 6 251 |
| Depreciation & amort. | −623 | −570 | −417 | −396 | −387 |
| EBIT | 4 740 | 961 | 3 138 | 3 519 | 5 863 |
| Net financials | 222 | 744 | −599 | 1 543 | 2 403 |
| Profit before tax | 4 962 | 1 705 | 2 539 | 5 062 | 8 266 |
| Tax | 1 044 | 212 | 690 | 733 | 1 167 |
| Net profit | 3 918 | 1 493 | 1 849 | 4 329 | 7 100 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 22 738 | 24 070 | 25 175 | 37 231 | 43 546 |
| Equity | 19 685 | 21 178 | 22 327 | 26 656 | 31 756 |
| Long-term debt | 0 | 0 | 0 | 8 395 | 8 055 |
| Short-term debt | 3 053 | 2 892 | 2 848 | 2 179 | 3 735 |
| Total debt | 3 053 | 2 892 | 2 848 | 10 574 | 11 790 |
EBITDA margin
64.3%
This company
15.8%
Market median
+307% vs market
20202024
Equity ratio
72.9%
This company
38.2%
Market median
+91% vs market
20202024
Return on equity
22.4%
This company
18.4%
Market median
+22% vs market
20202024
Net profit margin
73.1%
This company
8.1%
Market median
+802% vs market
20202024
Asset turnover
0.22×
This company
1.12×
Market median
-80% vs market
20202024
Debt / equity
0.37×
This company
0.62×
Market median
+40% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LL Deputy Member | Deputy Member | 2007 |
LE Chief Executive Officer | Chief Executive Officer | 2007 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LECARDIO AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Lesjø Erdal | Deputy Member | 0 companies |
| Leif Erik Erdal | Chief Executive Officer | 0 companies |